STORM Therapeutics has appointed Professor Paul Workman to its Board. Paul is CEO and president of The Institute of Cancer Research (ICR). He is Harrap Professor of Pharmacology and Therapeutics at the ICR, as well as the former Head of the Division of Cancer Therapeutics and former Director of the Cancer Research UK Cancer Therapeutics Unit from 1997-2016 – a period of 18 years.
